ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104
November 26, 2018Study C1104-001 was a First Time in Human, randomised, double blind, placebo controlled, parallel group study in healthy volunteers and patients with asthma to assess the safety, tolerability and pharmacokinetics of single ascending and repeat doses of ‘1 -
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104
November 26, 2018Study C1104-001 was a First Time in Human, randomised, double blind, placebo controlled, parallel group study in healthy volunteers and patients with asthma to assess the safety, tolerability and pharmacokinetics of single ascending and repeat doses of ‘1
Pharma Sources Insight January 2025
